Trails Edge Capital Partners, LP: 13F holdings
CIK 20772472026Q2
| Positions | 35 |
|---|
| Reported value | $629.9m |
|---|
| Filed | 2026-08-14 |
|---|
Change since last quarter
| Positions | 35 (+9 vs prior quarter) |
|---|
| Reported value | $629.9m (+44.3%) |
|---|
Top 10 holdings
| Security | Shares | Value | Weight |
|---|
| LBRX LB PHARMACEUTICALS INC | 1,523,022 | $49.4m | 7.8% |
| NRIX NURIX THERAPEUTICS INC | 1,573,220 | $38.2m | 6.1% |
| IMCR IMMUNOCORE HLDGS PLC | 1,063,234 | $33.8m | 5.4% |
| FIRST TRACKS BIOTHERAPEUTICS | 1,514,000 | $30.5m | 4.8% |
| FDMT 4D MOLECULAR THERAPEUTICS IN | 2,227,917 | $29.6m | 4.7% |
| BMRN BIOMARIN PHARMACEUTICAL INC | 512,000 | $29.3m | 4.7% |
| DSGN DESIGN THERAPEUTICS INC | 2,001,282 | $29.0m | 4.6% |
| XENE XENON PHARMACEUTICALS INC | 440,000 | $26.6m | 4.2% |
| MIRM MIRUM PHARMACEUTICALS INC | 223,312 | $26.1m | 4.2% |
| INSM INSMED INC | 230,331 | $24.6m | 3.9% |
Get the full book
import finzdata as yf
yf.Client().manager_holdings(cik="2077247")
Every position, quarter by quarter since 2013, with adds, trims and exits, on the look-back bundles.
Get a free API keySee history bundlesDownload free samples